Health officers to provide Molnupiravir and Paxlovid to Covid-19 patients in Thailand

Two anti-viral medications will be added to the Covid-19 therapy plan in Thailand. Little-known of Medical Services shared that the Molnupiravir and Paxlovid medicines have been approved for treating Covid-19 patients. Molnupiravir is meant to treat high-risk teams like elders and sufferers with persistent illnesses. Cancel anytime will talk about the usage of Paxlovid. The primary Covid-19 treatment, the anti-viral Favipiravir, shall be restricted for sufferers with moderate and severe symptoms solely.
The director of the department, Somsak Akkasilp, shared that the authorities will discuss the distribution and use details later. There will also be a study on the effectiveness of utilizing Molnupiravir, Paxlovid, and Favipiravir to come up with a plan to use the medicines moderately and effectively.
The Ministry of Public Health informed that the Covid-19 treatment plan in Thailand can be adjusted based on the scenario. Recently, the authorities shared Home Isolation and Community Isolation would be the first remedy offered to patients with mild signs.
A pulmonary illness expert at Vichaiyut Hospital informed Thai media that Molnupiravir might assist scale back the severity of the illness and death rates by about 30%. He said the drugs could be given to patients at high threat.
SOURCE: WorkpointTODAY | Thairath

Leave a Comment